Akari Therapeutics to Host Webinar on HSCT-TMA and the Potential of Nomacopan
Akari Therapeutics, Plc, a leading biotechnology company specializing in advanced therapies for autoimmune and inflammatory diseases, has announced its plans to host a virtual key opinion leader event on October 19, 2023, at 11:30 am ET. The primary focus of this event will be to discuss the patient care landscape for hematopoietic stem cell transplant-related […]
BD² Announces $18 Million in Grants to Understand Biology of Bipolar Disorder
BD²: Breakthrough Discoveries for Thriving with Bipolar Disorder has recently declared its inaugural round of Discovery Research grants, amassing a total of $18 million. This significant financial commitment is aimed at fostering collaboration and directing concentrated funding towards understanding the biology of bipolar disorder. Key Highlights: Conclusion: BD²’s commitment to understanding bipolar disorder, especially through […]
Rune Labs and Aspen Neuroscience Collaborate on Parkinson’s Disease Study
Rune Labs, a leading precision neurology software and data platform company, has joined forces with Aspen Neuroscience Inc., a prominent autologous cell therapy biotechnology firm. The collaboration aims to leverage Rune Labs’ StriveStudy clinical development platform, enabling Aspen to gather real-time, longitudinal patient data remotely. The primary objective of this partnership is to utilize the […]
$32.3M Boost: City of Hope’s Groundbreaking Therapies
City of Hope, a prominent cancer research and treatment organization in the United States, has received a grant of $32.3 million from the California Institute for Regenerative Medicine (CIRM). Funding Allocation The funds will be used to support three novel Phase 1 clinical trials that focus on innovative cell and gene therapy treatments for patients […]
Unlocking Health Regeneration: The Power of Exosomes
Welcome to our exploration of the fascinating world of exosomes and their potential in regenerative medicine. In the vast universe of our bodies, trillions of cells are constantly communicating and collaborating to keep us healthy. Imagine these cells as bustling cities, and within these cities, there are numerous messengers that carry vital information from one […]
Revolutionary Stem Cell Breakthrough Battles Gastroesophageal Cancer
The DeGregorio Family Foundation, with support from the Torrey Coast Foundation Gastro Esophageal Investigator Network Initiative (GEMINI), has awarded $300,000 to Dr. Saar Gill of the University of Pennsylvania. This award is in recognition of the progress he has made in less than a year on his grant, which is in addition to the $250,000 […]
Revolutionary Placental Biomaterials Transform Cell Therapy
Celularity Inc., a biotechnology company specializing in placental-derived allogeneic cell therapies and biomaterial products, has announced that it will present data on its proprietary extracellular matrices (ECM) at the International Conference on Biomaterials Science and Tissue Engineering (ICBSTE), taking place from July 24-26 in Osaka, Japan. The data includes benchtop and clinical case studies for […]
Stem Cells Unlock Cure: Sickle Cell Gene Therapy Revolution
The podcast episode titled “Stem Cell Gene Therapy Clinical Trial to eliminate Sickle Cell Disease” from Regen Med Global features Dr. Donald Kohn, a UCLA Professor for the Departments of Microbiology, Immunology & Molecular Genetics; Pediatrics; Molecular & Medical Pharmacology. Dr. Kohn begins by sharing his background, including his education and his interest in research […]
Unlocking Stem Cells: Revolution in Regenerative Medicine with Dr. Melihcan Sezgic
The video above is a presentation by Dr. Melih Can Sezgic at the Regenerative Medicine Symposium, where he discusses the role of stem cells in regenerative medicine, particularly in the fields of plastic, reconstructive, and aesthetic surgery. Here’s a detailed summary of the key points: Please note that this is a summary of a complex […]
Groundbreaking Cell Therapy NRTX-1001 Promises Over 90% Seizure Reduction: A New Hope for Drug-Resistant Epilepsy Patients
Neurona Therapeutics, a clinical-stage biotherapeutics company, has presented new data from its ongoing Phase I/II clinical trial of a one-time dose of NRTX-1001 in people with drug-resistant mesial temporal lobe epilepsy (MTLE). The data shows a promising reduction in seizure frequency in the first and second patients at one year and seven-months post-treatment, respectively. The […]